Risk analysis of hepatitis induced by immune checkpoint inhibitors based on FDA adverse events reporting system database

Yupei WU, Yuesong YIN, Zepu WANG, Liye GUAN, Lina ZHANG, Lingzhi FANG, Sujuan XUE, Hailing DI

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (9) : 70-76.

PDF(439 KB)
Welcome to visit Clinical Medication Journal!
PDF(439 KB)
Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (9) : 70-76. DOI: 10.3969/j.issn.1672-3384.2024.09.011
Original Article

Risk analysis of hepatitis induced by immune checkpoint inhibitors based on FDA adverse events reporting system database

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(9): 70-76 https://doi.org/10.3969/j.issn.1672-3384.2024.09.011

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(439 KB)

Accesses

Citation

Detail

Sections
Recommended

/